1 Min Read
April 4 (Reuters) - Biopharmx Corp :
* Biopharmx Health Canada approves study of violet iodine
* Results from this study are expected by end of 2016 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.